...that product. Taysha adds innovation source through gene therapy fundTaysha Gene Therapies Inc. (NASDAQ:TSHA) and the University of Texas Southwestern Medical Center...

...studies ribonucleoprotein granules and the role of that type of biomolecular condensate in neurodegenerative diseases; University of Texas Southwestern Medical Center’s Michael...

...Guangzhou Medical University, Guangzhou, Chinaemail: daolin.tang@utsouthwestern.eduCONTACT: Rui Kang, University of Texas Southwestern Medical Center, Dallas, Texasemail: rui.kang@utsouthwestern.edu Claire Quang Third Military Medical University University of Texas Southwestern Medical Center Sequestosome...

...al. Science; published online Sept. 25, 2020doi: 10.1126/science.abb7699 CONTACT: James J. Collins III, University of Texas Southwestern Medical Center, Dallas, Texasemail: jamesj.collins@utsouthwestern.edu Claire Quang University of Texas Southwestern Medical Center Serine/threonine...

...for a valuation of $716 million. Former AveXis Inc. executives spun Taysha out of the University of Texas Southwestern Medical Center...

...to raise up to $100 million in a NASDAQ IPO. Founded in partnership with the University of Texas Southwestern Medical Center...

...Investors”). A team of former AveXis Inc. executives spun Taysha Gene Therapies out of the University of Texas Southwestern Medical Center...
...Cytochrome c oxidase assembly factor Danielle Golovin, Staff Writer Zolgensma, onasemnogene abeparvovec-xioi, ScAAV9.CB.SMN (AVXS-101, charisma) AXO-AAV-GM2 Taysha Gene Therapies University of Texas Southwestern Medical Center AveXis...

...University of Massachusetts Medical School and Steven McKnight, chair of the biochemistry department at the University of Texas Southwestern Medical Center...

...Academy of Sciences (NAS). Schmid was chair of the Department of Cell Biology at the University of Texas Southwestern Medical Center...

...pipeline of AAV9-based gene therapies for other CNS disorders. The company spun out of the University of Texas Southwestern Medical Center...
...University of Texas Southwestern Medical Center Disease focus: Neurology Clinical status: Preclinical Founded: 2019 by R.A. Session II University collaborators: University of Texas Southwestern Medical Center...